Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development

Published: Dec 12, 2012

SUZHOU, China--(BUSINESS WIRE)--Crystal Pharmatech, one of the first solid state, technology-driven research laboratories to open in China adopting a Western approach to business and R&D, announced that it will offer customized materials science development service packages in drug discovery and development. Using a collaborative business model between customers and CMO’s that is relatively new to the pharmaceutical industry, Crystal Pharmatech's revenues have grown by 100% since it was founded in 2010 by a team whose former experience at top drug makers includes development of 200 new chemical entities (NCE's) and inventorship on 40 polymorph patents. Crystal Pharmatech continues to grow its present network of 50 partnerships including some of the world's leading pharmaceutical companies.

Back to news